Skip to main content
Clinical Trials/NL-OMON37950
NL-OMON37950
Recruiting
Not Applicable

An exploratory study to evaluate bladder contractions in the storage phase (non voiding activities) and related bladder sensation in healthy females and untreated females with Overactive Bladder (OAB) using high resolution and conventional urodynamics. - Exploratory urodynamic study to bladdercontractions in storage phase

Astellas Pharma0 sites45 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Frequency and Urgency
Sponsor
Astellas Pharma
Enrollment
45
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • Female subjects aged between 35 and 65 years
  • has signs and symptoms of OAB including urinary frequency, urgency or urge incontinence for greater than or equal to 3 months defined as:
  • \- At least 1 episode of urgency with or without incontinence in the last 3\-day micturition diary.
  • \- Frequency of micturition greater than or equal to 8 per 24 hours period during the 3\-day micturition diary period
  • Written informed consent
  • Healthy volunteers:
  • Healthy female subjects aged between 35 and 65 years .
  • Written informed consent

Exclusion Criteria

  • Exclusion criteria patients and healthy volunteers:
  • 1\. History of stress urinary incontinence, urethral sphincter incompetence, neurogenic detrusor overactivity and overactive bladder.
  • 2\. History, signs or symptoms suggestive of urinary tract infection (confirmed by positive urine analysis), bladder outlet obstruction (not including detrusor\-overactivity) for example bladder/vesicouterine pro\-lapse (\> grade II) or chronic obstruction.
  • 3\. History of urinary tract surgery less than or equal to 6 months prior to screening.
  • 4\. Has an indwelling catheter or permanent catheter fitted.
  • 5\. History of pelvic area radiotherapy treatment.
  • 6\. Uncontrolled diabetes mellitus.
  • 7\. History of fibromyalgia.
  • 8\. Pregnant or intends to become pregnant during the study or sexually active, of childbearing potential and is unwilling to utilize a reliable method of birth control (note: reliable methods are contraceptive pills of combination type, hormonal implants, injectable contraceptives, sexual abstinence or vasectomized partner).
  • 9\. Pregnancy within 6 months before screening or breast feeding within 3 months before screening

Outcomes

Primary Outcomes

Not specified

Similar Trials